ResearcherKindai University HospitalNo recent work listed

Yasumasa Nishimura Md

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4244-1309; OpenAlex author ID A5101486476. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2012: 1 paper

Papers 1

Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Last author DOI 10.1016/j.ijrobp.2011.07.013 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kazuhiko Ogawa · 1 shared paper, 2012 · strength 0.03
- Paper Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on … DOI 10.1016/j.ijrobp.2011.07.013 ↗
Keiko Shibuya · 1 shared paper, 2012 · strength 0.03
- Paper Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on … DOI 10.1016/j.ijrobp.2011.07.013 ↗
Hiroshi Onishi · 1 shared paper, 2012 · strength 0.03
- Paper Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on … DOI 10.1016/j.ijrobp.2011.07.013 ↗
Katsuyuki Karasawa · 1 shared paper, 2012 · strength 0.03
- Paper Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on … DOI 10.1016/j.ijrobp.2011.07.013 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.